P/E Ratio
Updated 321h ago
Sector Performance
72th percentileTRMB
34.7x
Sector Median
24.7x
Sector Avg
36.0x
Deep Analysis
The P/E ratio of 34.7x means investors are paying $34.70 for every $1 of the company's trailing earnings, indicating a premium valuation relative to profits.
This ratio sits above the sector median of 24.1x, placing TRMB in the 74th percentile among peers, meaning it is more expensive than three-quarters of similar companies. The trend data is not available because the year-over-year and quarter-over-quarter changes are both listed as N/A, and no historical values for the last eight quarters were provided. Without a trend, the current level alone suggests a higher valuation that may already reflect expected growth, limiting near-term upside while increasing downside risk if earnings disappoint. This combination of a premium P/E without a clear trend points to a cautious assessment, where further appreciation depends on continued performance. The elevated valuation relative to the sector median supports the overall NEUTRAL verdict, as it neither signals an obvious bargain nor outright overvaluation given the lack of trend data.
Frequently Asked Questions
What does the P/E Ratio tell investors about TRMB?
Measures how much investors pay per dollar of earnings. A high P/E signals growth expectations; a low P/E may indicate undervaluation or slow growth.
How is the P/E Ratio calculated?
P/E Ratio is calculated as: Price / EPS.
Who are TRMB's closest peers by P/E Ratio?
The closest peers by P/E Ratio include: VICI (9.1x), OMF (9.0x), JACK (8.5x), GIS (8.4x), FIS (8.4x).
The Formula
Price / EPS
Why It Matters
Measures how much investors pay per dollar of earnings. A high P/E signals growth expectations; a low P/E may indicate undervaluation or slow growth.
Master TRMB's Valuation
Get the complete institutional research report covering all fundamental and technical metrics.
View full TRMB research report →TRMB
34.7x
Sector Median
24.7x
Sector Avg
36.0x
How TRMB's P/E Ratio compares to sector peers.
Also Analyze
Not financial advice. Research tool only. Data may be delayed.